Terms: = Sarcomas AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Prognosis
1 results:
1. Immunomodulatory drugs target IKZF1-irf4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract] [Full Text] [Related]
